VADODARA, India, April 12 (Reuters) - Drug maker Alembic Ltd. plans to invest 600 million rupees over two years to set up a drug manufacturing facility even as it looks to bolster its international ...

Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2025 - Rediff ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Alembic Pharmaceuticals Ltd has obtained tentative approval from the USFDA for its Bosutinib tablets, used to treat specific ...

Alembic Pharmaceuticals secures USFDA tentative approval for 400 mg Bosutinib tablets, a generic cancer treatment option.

Alembic Pharmaceuticals receives USFDA tentative approval for generic Bosutinib tablets, a cancer treatment drug. ANDA ...

MUMBAI, June 29 (Reuters) - Drugmaker Alembic Ltd said on Tuesday its board approved the demerger of its core pharmaceuticals business into a separate unit, paving the way for the company's entry into ...

Case Name: Adverio Pharma Gmbh v. Alembic Pharms. Ltd., C.A. No. 18-73-LPS, 2019 U.S. Dist. LEXIS 23021 (D. Del. Feb. 13, 2019) (Stark, J.) Nature of Case and Issue(s) Presented: Plaintiffs have legal ...

Alembic Pharmaceuticals Ltd. Annual stock financials by MarketWatch. View the latest APLLTD financial statements, income statements and financial ratios.

Alembic Ltd. Annual stock financials by MarketWatch. View the latest ALEMBICLTD financial statements, income statements and financial ratios.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...